Recent Events & Catalysts
AbCellera Biologics Inc. (ABCL) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
AbCellera: Excellent Phase 2 Data In Menopause But The Platform Narrative Is Fading
SeekingAlpha · today
AbCellera Biologics Commences Underwritten Public Offering Of $200M Of Its Common Shares
Benzinga · today
Truist Securities Maintains Buy on AbCellera Biologics, Raises Price Target to $30
Benzinga · today
Here are the top movers in Monday's session.
ChartMill · 1d ago
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes Transcript
SeekingAlpha · 1d ago
There are notable gap-ups and gap-downs in today's session.
ChartMill · 1d ago
AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'
Benzinga · 1d ago
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes - Slideshow
SeekingAlpha · 1d ago
SEC Filings (90 days)
Regulation FD disclosure, Financial statements and exhibits
Filed 2026-08-10 · 2d ago
Other events, Financial statements and exhibits
Filed 2026-08-07 · 5d ago
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-08-05 · 7d ago · Material
Other events, Financial statements and exhibits
Filed 2026-07-29 · 14d ago
Departure/appointment of directors or officers, Financial statements and exhibits
Filed 2026-07-06 · 37d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.